Funding Details
- Date Award
- May 13, 2024
- Vertical
- Medtech
- Funding URL
- View Funding Page
Company Info
- Traction
- None
- Organizations Involved
- None
- Founders
- None
- Company Description
- BioLattice Ophthalmics, Inc. is addressing the need for tissue repair solutions, beginning with cornea. One in 70 patients who need cornea tissue obtain it. Globally 2 million per year suffer from corneal blindness while only 200,000 per year receive vision restoration via cornea transplant. Almost 13 million globally are on a donor cornea tissue waiting list. There is currently no standard of care alternative to donor cornea tissue for full thickness cornea transplant material. Our engineered cornea will be a true alternative to donor cornea while also offering corrective vision.
- Location
-
United States
- Coinvestors
- None
Links